A vitamin as neuromodulator: ascorbate release into the extracellular fluid of the brain regulates dopaminergic and glutamatergic transmission
GV Rebec, RC Pierce - Progress in neurobiology, 1994 - Elsevier
5.1. Interaction with the dopaminergic system 5.1. 1. Dopamine receptor binding
experiments 5.1. 2. Behavioral and biochemical evidence 5.2. Interaction with the …
experiments 5.1. 2. Behavioral and biochemical evidence 5.2. Interaction with the …
Brain dopamine receptors: a primer on their current status, basic and clinical
RJ Baldessarini, FI Tarazi - Harvard review of psychiatry, 1996 - Taylor & Francis
Recent progress in understanding the molecular biology and pharmacology of dopamine
receptors in mammalian brain has been remarkable and can serve as a basis for …
receptors in mammalian brain has been remarkable and can serve as a basis for …
Loss of autoreceptor functions in mice lacking the dopamine transporter
Autoreceptors provide an important inhibitory feedback mechanism for dopamine neurons
by altering neuronal functions in response to changes in extracellular levels of dopamine …
by altering neuronal functions in response to changes in extracellular levels of dopamine …
Biochemical and pharmacological studies on pramipexole, a potent and selective dopamine D2 receptor agonist
J Mierau, G Schingnitz - European journal of pharmacology, 1992 - Elsevier
Abstract Pramipexole (SND 919; 2-amino-4, 5, 6, 7-tetrahydro-6-propyl-amino-benzthiazole-
dihydrochloride) was tested for its agonistic activity at pre-and postsynaptic dopamine (DA) …
dihydrochloride) was tested for its agonistic activity at pre-and postsynaptic dopamine (DA) …
Spontaneous release of acetylcholine in striatum is preferentially regulated by inhibitory dopamine D2 receptors
P DeBoer, MJ Heeringa, ED Abercrombie - European journal of …, 1996 - Elsevier
The dose-related effects of the direct dopamine D2 receptor agonist quinpirole [trans-(−)-
4aR-4, 4a, 5, 6, 7, 8, 8a, 9-octahydro-5-propyl-1H-pyrazolo [3, 4-g] quinoline] on the …
4aR-4, 4a, 5, 6, 7, 8, 8a, 9-octahydro-5-propyl-1H-pyrazolo [3, 4-g] quinoline] on the …
Cerebrospinal fluid homovanillic acid predicts behavioral response to stimulants in 45 boys with attention deficit/hyperactivity disorder
FX Castellanos, J Elia, MJP Kruesi, WL Marsh… - …, 1996 - nature.com
Central dopaminergic activity has been assumed to play a role in the efficacy of stimulant
drugs in attention deficit/hyperactivity disorder (ADHD), although supporting evidence has …
drugs in attention deficit/hyperactivity disorder (ADHD), although supporting evidence has …
Functional correlates of dopamine D3 receptor activation in the rat in vivo and their modulation by the selective antagonist,(+)-S 14297: 1. Activation of postsynaptic D3 …
MJ Millan, JL Peglion, J Vian, JM Rivet, M Brocco… - … of Pharmacology and …, 1995 - ASPET
Using [125I]-iodosulpride as a radioligand, the novel naphthofurane,(+/-)-S 11566 [(+/-)-[7-
(N, N-dipropylamino)-5, 6, 7, 8-tetra-hydro-naphtho (2, 3b) dihydro, 2, 3-furane]) showed a …
(N, N-dipropylamino)-5, 6, 7, 8-tetra-hydro-naphtho (2, 3b) dihydro, 2, 3-furane]) showed a …
Partial agonist properties of the antipsychotics SSR181507, aripiprazole and bifeprunox at dopamine D2 receptors: G protein activation and prolactin release
C Cosi, E Carilla-Durand, MB Assié, AM Ormiere… - European journal of …, 2006 - Elsevier
Dopamine D2 receptor antagonists induce hyperprolactinemia depending on the extent of
D2 receptor blockade. We compared the effects of the new antipsychotic agents SSR181507 …
D2 receptor blockade. We compared the effects of the new antipsychotic agents SSR181507 …
Presynaptic receptors for dopamine, histamine, and serotonin
TJ Feuerstein - Pharmacology of Neurotransmitter Release, 2008 - Springer
Presynaptic receptors for dopamine, histamine and serotonin that are located on
dopaminergic, histaminergic and sertonergic axon terminals, respectively, function as …
dopaminergic, histaminergic and sertonergic axon terminals, respectively, function as …
Pramipexole, a dopamine D2 autoreceptor agonist, decreases the extracellular concentration of dopamine in vivo
AJ Carter, RE Müller - European journal of pharmacology, 1991 - Elsevier
Pramipexole (SND 919) is a dopamine D 2 autoreceptor agonist which is structurally related
to talipexole (B-HT 920), a potential antipsychotic agent. The aim of this study was to …
to talipexole (B-HT 920), a potential antipsychotic agent. The aim of this study was to …